Your browser doesn't support javascript.
loading
Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse.
Hahn, M; Böttcher, S; Dietrich, S; Hegenbart, U; Rieger, M; Stadtherr, P; Bondong, A; Schulz, R; Ritgen, M; Schmitt, T; Tran, T H; Görner, M; Herth, I; Luft, T; Schönland, S; Witzens-Harig, M; Zenz, T; Kneba, M; Ho, A D; Dreger, P.
  • Hahn M; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Böttcher S; Department Medicine II, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Dietrich S; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Hegenbart U; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Rieger M; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Stadtherr P; Praxis für Hämatologie und Onkologie, Darmstadt, Germany.
  • Bondong A; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Schulz R; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Ritgen M; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Schmitt T; Department Medicine II, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Tran TH; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Görner M; Transplantation Immunology, University of Heidelberg, Heidelberg, Germany.
  • Herth I; Städtisches Klinikum and Onkologische Praxis, Bielefeld, Germany.
  • Luft T; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Schönland S; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Witzens-Harig M; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Zenz T; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Kneba M; Department Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Ho AD; Department of Translational Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dreger P; Department Medicine II, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Bone Marrow Transplant ; 50(10): 1279-85, 2015 Oct.
Article en En | MEDLINE | ID: mdl-26146810
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante Homólogo / Leucemia Linfocítica Crónica de Células B / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante Homólogo / Leucemia Linfocítica Crónica de Células B / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article